Merck & Co., Inc. (NYSE:MRK)

Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Quotes

Merck, UnitedHealth Sink DJIA Wednesday

August 24, 2016: Markets opened lower Wednesday and only the Nasdaq Composite made even a brief visit to positive territory during the day's trading session. Healthcare and materials stocks led ...
Read Full Story »
money

How Much Medivation Can Really Fetch in a Buyout

Medivation Inc. (NASDAQ: MDVN) has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Slides

The short interest data have been released for the July 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
dividends

Short Sellers Look Worried About High-Yield Defensive Dividend Stocks

The short interest data for the July 29 settlement date are out. Investors and traders alike need to know that the short sellers are now fighting the market at all-time highs. ...
Read Full Story »
Stock market tickers

Amex, DuPont Drag on DJIA Tuesday

August 9, 2016: Markets opened higher again Tuesday following the lead of Asian and European exchanges. The productivity report cooled investors' enthusiasm, though, and afternoon trading saw equities slipping below ...
Read Full Story »
thinkstockphotos-522646895

Healthcare Stocks Sink DJIA on Monday

August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength ...
Read Full Story »
mind the gap

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Last week's news from Bristol-Myers Squibb Co. (NYSE: BMY) about Opdivo in first line non-small cell lung cancer missing its primary endpoint absolutely crushed its shares. It is just usual to ...
Read Full Story »
stock market

Merck Dominates DJIA Boost Friday

August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial and tech sectors led the gainers today, the former likely ...
Read Full Story »
analysis

Why Bristol-Myers Failure Is a Huge Win for Merck

Shares of Bristol-Myers Squibb Co. (NYSE: BMY) took a nosedive in Friday’s session following an update in its late-stage Checkmate trial. Unfortunately the results did not reach the primary endpoint, and ...
Read Full Story »
white pills

Merck Raises EPS Outlook After Q2 Earnings

Drug giant Merck & Co. Inc. (NYSE: MRK) reported second-quarter 2016 results before markets opened Friday. The company reported quarterly adjusted diluted earnings per share (EPS) of $0.93 and revenues ...
Read Full Story »
Prescription drugs

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
ThinkstockPhotos-475180302

Top Dow Earnings for the Week Ahead

Earnings season for the second quarter of the calendar year is underway, and 24/7 Wall St. has put together a preview of some of the major Dow Jones Industrial Average ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

The short interest data have been released for the June 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »